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Does it make sense to use a simple organism to study human disease? I am sure 
that all those scientists using non-mammalian models in biomedical research have 
faced this question many times, perhaps informally in front of the family and friends 
or in more critical situations under the scrutiny of grant agencies or evaluation 
committees. There are obvious arguments supported by the history of science 
telling us the usefulness of learning from simple models and how this has become 
essential to understand certain pathologies. In addition to the well-known 
conservation of genes and molecular pathways among distant species there are 
practical reasons, such as their simplicity and tractability compared with the 
complexity and the experimental inaccessibility of the human body. An added value 
from the studies of simple models is that, not infrequently, they open radically new 
perspectives in the study of a given pathology. This is often the result of applying 
unbiased genetic analysis and the opportunity in a model organism to address the 
function of a given gene in the organism as a whole. As a consequence, this 
research might not be translated immediately to human disease but serve as a 
ground for more applied approaches. As Louis Pasteur stated “There does not 
exist a category of science to which one can give the name applied science. There 
are sciences and the applications of science, bound together as the fruit of the tree 
which bears it”. This series of reviews exemplifies beautifully howthe social 
amoeba Dictyostelium fulfills all the requirements for a useful experimental model 
in understanding the basic principles of human disease. 
 
The Dictyostelium life style provides excellent opportunities to address disease-
related processes in a meaningful way. This soil amoeba predates bacteria in its 
natural environment. As a result of this selective pressure, bacteria developed 
strategies to survive which later were used and adapted to infect other organisms 
including humans. The reviews by Michael Steinert and Wanessa Lima et al. 
describe the use of Dictyostelium as a model to study the interaction with several 
pathogens of immense importance in human health such as Legionella, 
Mycobacterium and Pseudomonas. 
 
Social amoebae use motility and chemotaxis both to hunt bacteria and to 
aggregate collectively to form amulticellular organism. The underlying mechanisms 
driving these phenomena are essentially similar to those of mammalian cells, and 
thus Dictyostelium has become a prominent model in this field. Michael Carnell and 
Robert Insall review how research in Dictyostelium has contributed to our 
understanding of cell motility-related pathologies which includes deficiencies in the 
immune and neurological systems. One of these deficiencies is Lissencephaly, a 
severe brain disease caused by mutations in highly conserved genes present in 
Dictyostelium, LIS1 and DCX. The molecular roles of these proteins and others 
involved in this pathology are now beginning to be understood thanks in part to 
Dictyostelium. Irene Meyer et al. review our current knowledge of the molecular 
clues underlying Lissencephaly and describe invaluable new findings on the 
function of the Dictyostelium DCX protein. 
 
Dictyostelium has also proved its usefulness in pharmacogenomics helping to 
unveil the mechanism of action of certain drugs and at the same time to reduce the 
use of animals in research. Two wonderful topics have been reviewed in this issue. 
Stephen and Hannah Alexander explain how the isolation of a Dictyostelium 
mutant resistant to the cancer chemotherapeutic drug cysplatin prompted further 
studies in human cells on the role of sphingolipids and ceramide in regulating the 
response to this drug. Likewise, the review by Marthe Ludtmann et al. highlights 
our current knowledge of the mechanism of action of two commonly used 
bipolar disorder treatments (valproic acid and lithium).  
 
Human diseases associated with the endocytic and secretory pathway, such as 
Chediak Higashi Syndrome, Ceroid Lipofuscinosis and Niemann Pick Disease, 
originate severe symptoms affecting multiple organs and compromising the 
lifespan of affected patients. Markus Maniak here reviews current research in 
Dictyostelium related to the molecular basis of these complex diseases. Finally, 
Lisa Francione et al. address the complexity of the mitochondrial diseases and how 
the simplicity of Dictyostelium can help to uncover certain aspects of the 
cytopathological pathways involved. 
 
I hope this series of reviews will excite your curiosity and serve as a ground for 
further research using Dictyostelium as a model of human disease. It would also be 
gratifying if they help to convince those not working with simple models that this 
kind of research does indeed make sense. 
 
